Real-time enrollment status for this type 2 diabetes mellitus (t2dm) clinical trial
Current Status
Recruiting
Checked: October 22, 2026 at 1:12 AM UTC
| NCT Number | NCT07465224 |
| Recruiting Status | Recruiting |
| Condition | Type 2 Diabetes Mellitus (T2DM) |
| Phase | PHASE2 |
| Target Enrollment | 24 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Alnylam Pharmaceuticals |
| Last Updated on CT.gov | October 20, 2026 (2 days ago) |
As of October 22, 2026: Clinical trial NCT07465224 is currently recruiting participants. This phase2 study for type 2 diabetes mellitus (t2dm) is actively seeking new participants at 1 location across the United States. The study is sponsored by Alnylam Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07465224 is actively recruiting participants as of October 22, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07465224 was last updated 2 days ago (October 20, 2026). HelloStudys verifies this status automatically.